215 related articles for article (PubMed ID: 24780592)
1. Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK-VEGFR3 protein-protein interaction.
Gogate PN; Ethirajan M; Kurenova EV; Magis AT; Pandey RK; Cance WG
Eur J Med Chem; 2014 Jun; 80():154-166. PubMed ID: 24780592
[TBL] [Abstract][Full Text] [Related]
2. A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.
Kurenova E; Ucar D; Liao J; Yemma M; Gogate P; Bshara W; Sunar U; Seshadri M; Hochwald SN; Cance WG
Cell Cycle; 2014; 13(16):2542-53. PubMed ID: 25486195
[TBL] [Abstract][Full Text] [Related]
3. Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.
Kurenova EV; Hunt DL; He D; Magis AT; Ostrov DA; Cance WG
J Med Chem; 2009 Aug; 52(15):4716-24. PubMed ID: 19610651
[TBL] [Abstract][Full Text] [Related]
4. The FAK scaffold inhibitor C4 disrupts FAK-VEGFR-3 signaling and inhibits pancreatic cancer growth.
Kurenova E; Liao J; He DH; Hunt D; Yemma M; Bshara W; Seshadri M; Cance WG
Oncotarget; 2013 Oct; 4(10):1632-46. PubMed ID: 24142503
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 1,2,4-triazine scaffold as FAK inhibitors with antitumor activity.
Dao P; Lietha D; Etheve-Quelquejeu M; Garbay C; Chen H
Bioorg Med Chem Lett; 2017 Apr; 27(8):1727-1730. PubMed ID: 28284808
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor.
Fang Y; Wang D; Xu X; Liu J; Wu A; Li X; Xue Q; Wang H; Wang H; Zhang H
Eur J Med Chem; 2017 Feb; 127():493-508. PubMed ID: 28109944
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.
Wang R; Zhao X; Yu S; Chen Y; Cui H; Wu T; Hao C; Zhao D; Cheng M
Bioorg Chem; 2020 Sep; 102():104092. PubMed ID: 32707280
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents.
Tan H; Liu Y; Gong C; Zhang J; Huang J; Zhang Q
Eur J Med Chem; 2021 Nov; 223():113670. PubMed ID: 34214842
[TBL] [Abstract][Full Text] [Related]
9. Development of focal adhesion kinase inhibitors in cancer therapy.
Ma WW
Anticancer Agents Med Chem; 2011 Sep; 11(7):638-42. PubMed ID: 21787276
[TBL] [Abstract][Full Text] [Related]
10. Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach.
Kumar V; Singh P; Parate S; Singh R; Ro HS; Song KS; Lee KW; Park YM
J Mol Graph Model; 2024 Jul; 130():108789. PubMed ID: 38718434
[TBL] [Abstract][Full Text] [Related]
11. Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).
Lu Y; Sun H
J Med Chem; 2020 Dec; 63(23):14382-14403. PubMed ID: 33058670
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.
Duan YT; Yao YF; Huang W; Makawana JA; Teraiya SB; Thumar NJ; Tang DJ; Tao XX; Wang ZC; Jiang AQ; Zhu HL
Bioorg Med Chem; 2014 Jun; 22(11):2947-54. PubMed ID: 24792811
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
[TBL] [Abstract][Full Text] [Related]
14. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
Chauhan A; Khan T
Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
[TBL] [Abstract][Full Text] [Related]
15. Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer.
Gogate PN; Kurenova EV; Ethirajan M; Liao J; Yemma M; Sen A; Pandey RK; Cance WG
Cancer Lett; 2014 Oct; 353(2):281-9. PubMed ID: 25067788
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Design, Synthesis, and Characterization of the First Irreversible Inhibitor of Focal Adhesion Kinase.
Yen-Pon E; Li B; Acebrón-Garcia-de-Eulate M; Tomkiewicz-Raulet C; Dawson J; Lietha D; Frame MC; Coumoul X; Garbay C; Etheve-Quelquejeu M; Chen H
ACS Chem Biol; 2018 Aug; 13(8):2067-2073. PubMed ID: 29897729
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular docking studies of novel 2-(1,3,4-oxadiazol-2-ylthio)-1-phenylethanone derivatives.
Zhang LR; Liu ZJ; Zhang H; Sun J; Luo Y; Zhao TT; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Jun; 20(11):3615-21. PubMed ID: 22541051
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma.
Li B; Li Y; Tomkiewicz-Raulet C; Dao P; Lietha D; Yen-Pon E; Du Z; Coumoul X; Garbay C; Etheve-Quelquejeu M; Chen H
J Med Chem; 2020 Nov; 63(21):12707-12724. PubMed ID: 33119295
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.
Garces CA; Kurenova EV; Golubovskaya VM; Cance WG
Cancer Res; 2006 Feb; 66(3):1446-54. PubMed ID: 16452200
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of a real-time activity probe for focal adhesion kinase.
Beck JR; Zhou X; Casey GR; Stains CI
Anal Chim Acta; 2015 Oct; 897():62-8. PubMed ID: 26515006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]